Articles published by NexImmune, Inc.

NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
February 06, 2024
From NexImmune, Inc.
Via GlobeNewswire
Tickers
NEXI

NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
February 02, 2024
From NexImmune, Inc.
Via GlobeNewswire
Tickers
NEXI


NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting
October 19, 2023
From NexImmune, Inc.
Via GlobeNewswire
Tickers
NEXI

NexImmune Announces 1-for-25 Reverse Stock Split
October 18, 2023
From NexImmune, Inc.
Via GlobeNewswire
Tickers
NEXI

NexImmune Announces Workforce Reduction to Enable Continued AIMTM Nanoparticle Platform Development Strategy
August 31, 2023
From NexImmune, Inc.
Via GlobeNewswire
Tickers
NEXI

NexImmune Reports Second Quarter 2023 Financial Results and Provides Business Updates
August 10, 2023
From NexImmune, Inc.
Via GlobeNewswire
Tickers
NEXI

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free